FMISO-based adaptive radiotherapy in head and neck cancer

M Dolezel, M Slavik, T Blazek, T Kazda… - Journal of Personalized …, 2022 - mdpi.com
Concurrent chemoradiotherapy represents one of the most used strategies in the curative
treatment of patients with head and neck (HNC) cancer. Locoregional failure is the …

[HTML][HTML] Impact of interstitial lung abnormality on survival after adjuvant durvalumab with chemoradiotherapy for locally advanced non-small cell lung cancer

T Kashihara, Y Nakayama, K Okuma… - Radiotherapy and …, 2023 - Elsevier
Introduction Concurrent chemoradiotherapy (CCRT) has been the standard of care for
patients with locally advanced non-small cell lung cancer (LA-NSCLC). Background and …

Prognostic factor analysis of definitive radiotherapy using intensity-modulated radiation therapy and volumetric modulated arc therapy with boluses for scalp …

T Kashihara, H Igaki, D Ogata, H Nakayama… - Scientific Reports, 2022 - nature.com
Cutaneous angiosarcomas is a rare cancer with poor prognoses. The common radiotherapy
techniques that have been reported so far are two pairs of lateral X-ray and electron fields …

Clinical significance of local control of primary tumour in definitive radiotherapy for scalp angiosarcomas

T Kashihara, D Ogata, K Okuma… - Skin Research and …, 2023 - Wiley Online Library
Introduction Scalp angiosarcoma is a rare and aggressive cancer. Definitive radiotherapy is
a treatment option for localised scalp angiosarcoma patients. Although definitive surgical …

Radiotherapy with genomic-adjusted radiation dose

T Kashihara, K Kashihara - The Lancet Oncology, 2021 - thelancet.com
We read the Article by Jacob G Scott and colleagues1 with great interest. The biological
effect of radiotherapy quantified by the genomic-adjusted radiation dose (GARD) is …